First Trust · 2016-09-20 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$21.0M | — | — | $36.2M | 每日估算 |
| 2026-07-30 | +$1.2M | — | — | $57.5M | 每日估算 |
| 2026-07-29 | -$806,345 | — | — | $56.6M | 每日估算 |
| 2026-07-28 | +$20.2M | — | — | $56.5M | 每日估算 |
| 2026-07-27 | -$135,360 | — | — | $36.2M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
JNJ Johnson & Johnson COM | EC | 8,893 | $2.2M | 7.45% |
BMY Bristol-Myers Squibb Company COM | EC | 35,422 | $2.1M | 7.36% |
MRK Merck & Co., Inc COM | EC | 17,843 | $2.1M | 7.36% |
ABBV AbbVie Inc. COM | EC |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-26 | -$20.3M | — | — | $36.2M | 每日估算 |
| 2026-07-25 | -$210,254 | — | — | $56.3M | 每日估算 |
| 2026-03-31 | $0 | $0 | $0 | $29.2M | SEC 月度 |
| 2026-02-28 | +$5.3M | $5.3M | $0 | — | SEC 月度 |
| 2026-01-31 | +$1.7M | $1.7M | $0 | — | SEC 月度 |
| 9,520 |
| $2.1M |
| 7.10% |
LLY Eli Lilly & Co. COM | EC | 2,100 | $1.9M | 6.62% |
PFE Pfizer Inc. COM | EC | 39,951 | $1.1M | 3.85% |
REGN Regeneron Pharmaceuticals, Inc. COM | EC | 1,413 | $1.1M | 3.74% |
BIIB Biogen Inc COM | EC | 5,759 | $1.1M | 3.62% |
GILD Gilead Sciences Inc. COM | EC | 7,416 | $1.0M | 3.54% |
CAH Cardinal Health, Inc. COM | EC | 4,819 | $1.0M | 3.49% |
AMGN Amgen Inc. COM | EC | 2,846 | $1.0M | 3.43% |
VTRS Viatris Inc COM | EC | 73,989 | $999,591 | 3.43% |
ZTS Zoetis Inc. CL A | EC | 8,426 | $996,037 | 3.41% |
VRTX Vertex Pharmaceuticals Incorporated COM | EC | 2,223 | $992,658 | 3.40% |
UTHR United Therapeutics Corporation COM | EC | 1,630 | $966,557 | 3.31% |
INCY Incyte Corporation. COM | EC | 6,843 | $644,063 | 2.21% |
JAZZ Jazz Pharmaceuticals PLC SHS USD | EC | 3,347 | $632,750 | 2.17% |
ILMN Illumina Inc COM | EC | 3,657 | $450,762 | 1.55% |
EXEL Exelixis, Inc. COM | EC | 10,279 | $440,866 | 1.51% |
MEDP Medpace Holdings Inc. COM | EC | 865 | $415,364 | 1.42% |
PTCT PTC Therapeutics, Inc. COM | EC | 5,449 | $371,240 | 1.27% |
CRL Charles River Laboratories International, Inc. COM | EC | 2,127 | $366,908 | 1.26% |
BMRN Biomarin Pharmaceutical Inc. COM | EC | 6,318 | $356,904 | 1.22% |
NBIX Neurocrine Biosciences Inc COM | EC | 2,630 | $346,476 | 1.19% |
HALO Halozyme Therapeutics Inc COM | EC | 5,005 | $323,473 | 1.11% |
ALKS Alkermes PLC SHS | EC | 8,380 | $296,317 | 1.02% |
ELAN Elanco Animal Health Inc COM | EC | 10,925 | $261,435 | 0.90% |
SYRE Spyre Therapeutics Inc COM NEW | EC | 3,533 | $178,205 | 0.61% |
PTGX Protagonist Therapeutics Inc COM | EC | 1,650 | $173,910 | 0.60% |
TGTX TG Therapeutics Inc COM | EC | 5,049 | $167,728 | 0.57% |
ARWR Arrowhead Pharmaceuticals Inc COM | EC | 2,611 | $163,710 | 0.56% |
CPRX Catalyst Pharmaceuticals Inc. COM | EC | 6,583 | $162,995 | 0.56% |
AMRX Amneal Pharmaceuticals Inc COM STK CL A | EC | 12,984 | $161,391 | 0.55% |
RCUS Arcus Biosciences Inc. COM | EC | 7,459 | $161,114 | 0.55% |
TWST Twist Bioscience Corporation COM | EC | 3,238 | $153,870 | 0.53% |
LGND Ligand Pharmaceuticals Incorporated COM NEW | EC | 766 | $152,932 | 0.52% |
MIRM Mirum Pharmaceuticals Inc. COM | EC | 1,646 | $152,057 | 0.52% |
TVTX Travere Therapeutics Inc COM | EC | 5,100 | $151,521 | 0.52% |
ALNY Alnylam Pharmaceuticals Inc. COM | EC | 456 | $150,877 | 0.52% |
GH Guardant Health Inc COM | EC | 1,618 | $149,455 | 0.51% |
ROIV Roivant Sciences Ltd SHS | EC | 5,250 | $145,425 | 0.50% |
MRNA Moderna Inc COM | EC | 2,836 | $144,069 | 0.49% |
SUPN Supernus Pharmaceuticals, Inc COM | EC | 2,776 | $143,491 | 0.49% |
KRYS Krystal Biotech Inc COM | EC | 551 | $142,334 | 0.49% |
TARS Tarsus Pharmaceuticals Inc COM | EC | 2,012 | $141,142 | 0.48% |
IONS Ionis Pharmaceuticals, Inc. COM | EC | 1,872 | $140,568 | 0.48% |
TXG 10X Genomics Inc CL A COM | EC | 6,591 | $139,927 | 0.48% |
KYMR Kymera Therapeutics Inc COM | EC | 1,663 | $138,511 | 0.47% |
ACAD Acadia Pharmaceuticals Inc COM | EC | 6,186 | $137,700 | 0.47% |
ARQT Arcutis Biotherapeutics Inc. COM | EC | 5,633 | $132,713 | 0.45% |
MISXX Dreyfus Government Cash Management Funds SH BEN INT | STIV | 32,295 | $32,295 | 0.11% |